Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Horizon Two: HR NDMM (MMRC-100)High Risk Newly Diagnosed Multiple MyelomaRecruitingPhase 22026-10-02NCT07053436

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Multiple Myeloma Research Consortium9

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Atrium Levine Cancer instituteCharlotteUnited States2
Beth Israel Deaconess Medical CenterBostonUnited States462
City of HopeDuarteUnited States238
Emory UniversityAtlantaUnited States1
Karmanos Cancer InstituteDetroitUnited States153
Mayo ClinicRochesterUnited States68
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Mt. Sinai School of MedicineNew YorkUnited States5
Tennessee OncologyNashvilleUnited States77
UChicago MedicineChicagoUnited States5
UNCChapel HillUnited States2
Washington University Medical CenterSt LouisUnited States2